C

제이에스링크

127120KOSDAQ자연과학 및 공학 연구개발업

54.5 / 100

Reference Date: 2026-07-24

Financial Score10.0 / 40
News Sentiment17.5 / 25
Momentum12.0 / 20
Disclosure15.0 / 15
AI Analysis: PBR raises overvaluation concerns, Operating Profit is on a declining trend. Roughly flat over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

JS Link operates in genomics analysis, personalized medicine, and diagnostics, leveraging advancements in genomic technology and rising demand for customized treatments. As genome sequencing costs have drastically decreased and bioinformatics becomes crucial for handling large data, the molecular diagnostics market is rapidly expanding. Establishing Asia-specific genomic databases is key to securing global competitiveness.

Number of Employees

139people

Average Salary

53.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 43.644.0Point
PBR
17.70Industry Average 2.520.0Point

7.0x industry avg (risky)

ROE
-35.13Industry Average -32.093.5Point

In line with industry avg

Debt Ratio
9.28Industry Average 7.312.0Point

Higher than industry avg (caution)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼3.0% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼73.4% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -32.6% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 1Neutral 1Negative 0Average Sentiment Score 70

Detailed Momentum

52-week position6.0Point

52w upper range (60%)

Current 34,950Won52-week high 48,90052-week low 13,830
1-month return3.0Point

1m -0.57% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

10 totalPositive 3Neutral 7Negative 0
  • Positive[기재정정]주요사항보고서(유상증자결정)2026-07-21
  • Positive[기재정정]주요사항보고서(유상증자결정)2026-07-15
  • Positive주요사항보고서(유상증자결정)2026-07-07
  • Neutral기업설명회(IR)개최2026-07-07
  • Neutral주식등의대량보유상황보고서(약식)2026-07-01